Carl J Lavie Selected Research

Carl J Lavie Research Topics

Disease

74	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 01/2002
44	Heart Failure 05/2022 - 03/2004
41	Hypertension (High Blood Pressure) 06/2022 - 12/2005
35	Myocardial Infarction 03/2022 - 01/2002
34	Coronary Disease (Coronary Heart Disease) 01/2022 - 02/2002
32	Obesity 05/2022 - 01/2008
28	Stroke (Strokes) 08/2021 - 01/2002
24	COVID-19 07/2022 - 01/2020
21	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2008
18	Inflammation (Inflammations) 09/2022 - 01/2008
18	Weight Loss (Weight Reduction) 05/2022 - 03/2004
18	Coronary Artery Disease (Coronary Atherosclerosis) 09/2021 - 06/2002
17	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 07/2003
16	Atherosclerosis 01/2022 - 01/2003
15	Dyslipidemias (Dyslipidemia) 01/2022 - 12/2005
15	Acute Coronary Syndrome 12/2020 - 01/2008
14	Neoplasms (Cancer) 10/2020 - 11/2013
12	Hemorrhage 04/2022 - 03/2008
10	Thrombosis (Thrombus) 12/2021 - 01/2016
10	Insulin Resistance 12/2021 - 09/2007
10	Diabetes Mellitus 12/2019 - 05/2008
9	Atrial Fibrillation 12/2021 - 03/2008
6	Body Weight (Weight, Body) 01/2022 - 07/2006
5	Chronic Disease (Chronic Diseases) 07/2022 - 01/2008
5	Weight Gain 09/2020 - 01/2009
5	Overweight 01/2018 - 12/2009
5	Hypertriglyceridemia 01/2014 - 12/2005
4	Systolic Heart Failure 10/2021 - 01/2013
4	Vitamin D Deficiency 01/2021 - 10/2011
4	Hypercholesterolemia 12/2020 - 05/2008
4	Noncommunicable Diseases 09/2018 - 01/2016
4	Cardiac Sudden Death (Sudden Cardiac Arrest) 03/2008 - 01/2002
3	Infections 10/2020 - 01/2020
3	Hyperlipidemias (Hyperlipidemia) 06/2020 - 05/2004
3	Chronic Renal Insufficiency 01/2019 - 12/2011
3	Sleep Initiation and Maintenance Disorders (Insomnia) 05/2018 - 09/2013
3	Hyperglycemia 01/2018 - 04/2011
3	Abdominal Obesity 11/2013 - 12/2005
3	Prehypertension 11/2013 - 03/2011
3	Dementia (Dementias) 09/2012 - 01/2005

Drug/Important Bio-Agent (IBA)

26	LipidsIBA 09/2021 - 05/2004
21	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 05/2008
21	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 03/2004
14	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 12/2021 - 01/2002
12	HDL CholesterolIBA 01/2022 - 12/2005
11	CholesterolIBA 09/2022 - 01/2008
11	Triglycerides (Triacylglycerol)IBA 06/2022 - 01/2008
10	C-Reactive ProteinIBA 01/2022 - 03/2004
9	LDL CholesterolIBA 07/2022 - 01/2008
9	Fish OilsIBA 01/2014 - 01/2002
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2021 - 01/2013
7	Pharmaceutical PreparationsIBA 06/2022 - 03/2012
6	oxidized low density lipoproteinIBA 07/2022 - 01/2008
6	SodiumIBA 12/2021 - 01/2018
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 07/2008
6	Oxygen (Dioxygen)IBA 09/2020 - 03/2004
6	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 03/2011
6	Coffee FDA Link 05/2018 - 11/2011
6	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2018 - 01/2013
5	Eicosapentaenoic AcidIBA 12/2019 - 01/2002
5	Vitamin D FDA LinkGeneric 01/2017 - 10/2011
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021 - 08/2009
4	CytokinesIBA 09/2020 - 07/2006
4	Angiotensin-Converting Enzyme 2IBA 01/2020 - 01/2020
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 07/2013
4	Fibric Acids (Fibrates)IBA 11/2017 - 05/2004
4	Carvedilol (Coreg)FDA LinkGeneric 01/2015 - 03/2012
3	LDL Lipoproteins (beta Lipoproteins)IBA 06/2022 - 12/2005
3	AnticoagulantsIBA 06/2022 - 01/2015
3	VaccinesIBA 01/2022 - 07/2021
3	Biological ProductsIBA 01/2022 - 12/2020
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 07/2019
3	CalciumIBA 01/2022 - 11/2013
3	Warfarin (Coumadin)FDA LinkGeneric 12/2021 - 01/2014
3	Troponin IIBA 10/2021 - 05/2020
3	AntioxidantsIBA 03/2021 - 07/2011
3	Insulin (Novolin)FDA Link 03/2020 - 01/2019
3	DiureticsIBA 01/2019 - 04/2011
3	Caffeine (No Doz)FDA LinkGeneric 05/2018 - 09/2013
3	Ezetimibe (Zetia)FDA Link 01/2017 - 05/2004
3	Carnitine (L-Carnitine)FDA LinkGeneric 01/2014 - 06/2013
3	Docosahexaenoic AcidsIBA 01/2014 - 01/2002
3	Cilostazol (Pletal)FDA LinkGeneric 10/2013 - 01/2008
3	Indicators and Reagents (Reagents)IBA 09/2013 - 01/2012
3	Atorvastatin (Lipitor)FDA Link 01/2013 - 01/2008

Therapy/Procedure

61	Therapeutics 07/2022 - 01/2002
43	Cardiac Rehabilitation 03/2022 - 02/2002
23	Secondary Prevention 01/2016 - 01/2002
9	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2021 - 03/2009
9	Percutaneous Coronary Intervention 11/2021 - 03/2009
8	Stents 01/2021 - 01/2013
7	Heart Transplantation (Grafting, Heart) 01/2021 - 09/2006
5	Drug Therapy (Chemotherapy) 09/2021 - 12/2005
4	Artificial Respiration (Mechanical Ventilation) 07/2022 - 01/2020
4	Bariatric Surgery 11/2021 - 01/2018
4	Heart-Assist Devices 01/2021 - 08/2020
4	Resistance Training 10/2014 - 10/2013
3	Exercise Therapy (Therapy, Exercise) 01/2022 - 09/2011
3	Immunomodulation 09/2020 - 01/2020
3	Glycemic Control 07/2019 - 02/2011